Antech, part of Mars Veterinary Health, announced today that Lonnie Shoff will join the company as President of Diagnostics and Sound Operations as of April 15.
Under Shoff’s leadership, Antech will accelerate its development and commercialization of innovative diagnostic tests, predictive diagnostic tools, imaging technologies and education and support services.
“I am excited to lead the next chapter of Antech’s 30-year history,” said Shoff. “By applying innovative discoveries, data-driven insights and advanced imaging technologies, Antech will continue finding new ways to provide veterinarians with tools to advance the standards of care in pet health. I’m inspired by and proud to be part of such a purpose-driven company focused on creating A Better World for Pets.”
Throughout her 30-year career, Shoff has helped define new standards of human and animal healthcare through strategic positions with Thermo Fisher Scientific, Henry Schein and Roche Diagnostics, most recently serving as President of the Clinical Diagnostics Division at Thermo Fisher Scientific. Prior to this role, she was CEO of the Global Animal Health and Strategic Partnership Group at Henry Schein. Shoff also held a 21-year tenure at Roche Diagnostics as Senior Vice President and General Manager of Molecular Diagnostics and Applied Science.
“More than 14,000 veterinary hospitals depend on Antech’s personalized, care-centered medicine to help them deliver exceptional care each day,” she said. “I believe Antech is uniquely able to provide them with a comprehensive solution that reflects a unique focus on innovation, the intelligence gained from data and the talent and dedication of its associates.”